CBT
AZN icon

Central Bank & Trust’s AstraZeneca AZN Stock Holding History

Central Bank & Trust’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-149
Closed -$23.2K – 201
2024
Q2 		$23.2K Sell
149
-248
-62% -$37.3K ﹤0.01% 279
2024
Q1 		$53.7K Sell
397
-21
-5% -$2.78K 0.01% 239
2023
Q4 		$56.2K Sell
418
-177
-30% -$23K 0.01% 238
2023
Q3 		$80.6K Sell
595
-33
-5% -$4.51K 0.01% 201
2023
Q2 		$89.9K Sell
628
-111
-15% -$16.3K 0.02% 196
2023
Q1 		$103K Sell
739
-59
-7% -$7.94K 0.02% 192
2022
Q4 		$108K Hold
798
– – 0.02% 196
2022
Q3 		$88K Sell
798
-90
-10% -$11.4K 0.02% 192
2022
Q2 		$117K Sell
888
-394
-31% -$51.7K 0.02% 190
2022
Q1 		$170K Hold
1,282
– – 0.03% 177
2021
Q4 		$149K Sell
1,282
-135
-10% -$15.9K 0.02% 182
2021
Q3 		$170K Buy
1,417
+42
+3% +$4.89K 0.03% 166
2021
Q2 		$165K Hold
1,375
– – 0.03% 171
2021
Q1 		$137K Hold
1,375
– – 0.02% 170
2020
Q4 		$137K Buy
1,375
+89
+7% +$9.43K 0.02% 161
2020
Q3 		$141K Buy
+1,286
New +$143K 0.03% 159

Other funds holding AZN

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Sanders Capital
Sanders Capital West Palm Beach, Florida $99.8B AUM 47.9% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Central Bank & Trust's AZN Position: Q3 2024 in Review

Central Bank & Trust sold out of AstraZeneca (AZN) in Q3 2024, closing a stake of 149 shares — an estimated $23.2K sold.

Central Bank & Trust first reported a position in AZN in Q3 2020 and held it in 16 quarters. The position peaked at $170K in Q1 2022. 1,230 funds tracked by Wall St. Rank hold AZN as of Q3 2024.

  • Central Bank & Trust reported no remaining AstraZeneca position as of Q3 2024 after selling out during the quarter.
  • Central Bank & Trust sold 149 AstraZeneca shares in Q3 2024, an estimated $23.2K.
  • Central Bank & Trust first reported a position in AstraZeneca in Q3 2020 and held it in 16 quarters.
  • Central Bank & Trust's AstraZeneca position peaked at $170K in Q1 2022.
  • 1,230 funds tracked by Wall St. Rank held AstraZeneca as of Q3 2024.

Based on Central Bank & Trust's 13F filing for Q3 2024, filed 30 Oct 2024.